Sagimet Biosciences, Inc. Class A (SGMT) Balance Sheet
458 Followers
Sagimet Biosciences, Inc. Class A Balance Sheet
Sagimet Biosciences, Inc. Class A's total assets for Q3 2024 were $174.78M, a decrease of -7.54% from the previous quarter. SGMT total liabilities were $4.09M for the fiscal quarter, a -28.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.